P1‐260: Tg2576 mice have defective lipoprotein endocytosis
David Riddell(Eli Lilly (United States)), Peter H. Reinhart(University of Massachusetts Amherst), Menelas N. Pangalos(AstraZeneca (United Kingdom)), Michael M. Monaghan(Princeton University), Janice E. Chin(Bristol-Myers Squibb (Germany)), Wenyan Zhong(Huazhong Agricultural University), Wendy Stewart(Pfizer (United States)), Ernst Wagner(Center for NanoScience), Kaustubh Kishor Saraf(Pfizer (United States)), Helen K. Warwick(Princeton University), David von Schack(Pfizer (United States)), Zhen Lou, Kangwen Deng(Pfizer (United States)), Suzan Aschmies(Princeton University), Zhenyu Cao(Hunan Normal University)
Cited by 0
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Nomenclature for Synthetic Gene Delivery Systems
|Human Gene Therapy|1997|450
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302